Skip Navigation LinksHome > July/August 2014 - Volume 38 - Issue 4 > Can Full-Dose Contrast-Enhanced CT Be Omitted From an FDG-PE...
Text sizing:
A
A
A
Journal of Computer Assisted Tomography:
doi: 10.1097/RCT.0000000000000067
Thoracic Imaging

Can Full-Dose Contrast-Enhanced CT Be Omitted From an FDG-PET/CT Staging Examination in Newly Diagnosed FDG-Avid Lymphoma?

van Hamersvelt, Hanneke P. MD*; Kwee, Thomas C. MD, PhD*; Fijnheer, Rob MD, PhD; Beek, Frederik J.A. MD, PhD*; de Klerk, John M.H. MD, PhD; Nievelstein, Rutger A.J. MD, PhD*

Collapse Box

Abstract

Objective: To determine whether full-dose contrast-enhanced computed tomography (CT) (CECT) can be omitted from an 18F-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) (FDG-PET)/CT staging examination in newly diagnosed FDG-avid lymphoma.

Methods: Twenty-nine patients with newly diagnosed FDG-avid lymphoma prospectively underwent unenhanced low-dose FDG-PET/CT and CECT. Different observers evaluated unenhanced low-dose FDG-PET/CT and CECT in a blinded manner. Ann Arbor stages according to unenhanced low-dose FDG-PET/CT and CECT were compared, and discrepancies between the 2 imaging modalities were resolved using bone marrow biopsy and posttreatment FDG-PET/CT as reference standard. Finally, it was assessed as to how many cases therapy would have been changed based on additional CECT findings.

Results: In 27 of 29 patients (93%; 95% confidence interval, 78%–98%), CECT either did not change or did not correctly change the Ann Arbor stage that was assigned according to unenhanced low-dose FDG-PET findings. In 2 of 29 patients (7%; 95% confidence interval, 2%–22%), CECT correctly provided another Ann Arbor stage than unenhanced low-dose FDG-PET/CT. In the latter 2 cases, therapy would not have been changed based on additional CECT findings.

Conclusions: Unenhanced low-dose FDG-PET/CT alone is suggested as the primary imaging modality of choice for staging patients with newly diagnosed FDG-avid lymphoma. This diagnostic approach is particularly indicated in younger patients in whom diagnostic radiation exposure should be minimized and in patients who are at increased risk of CT contrast-induced allergic reactions or nephropathy.

© 2014 by Lippincott Williams & Wilkins

  

Login

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.